Institute of Cancer Research. ICR scientists on this site and elsewhere pioneered numerous new cancer drugs from the 1950s until the present day - including the discovery of chemotherapy drug carboplatin, prostate drug abiraterone and the genetic targeting of olaparib for ovarian and breast cancer